Drugs in Chronic Kidney Disease: Implications for Pharmacists

Tags: Online learning, Medication therapy management, Chronic conditions


Please note that this course is included in the OPA Clinical Bundle.

Chronic kidney disease (CKD) is the term used to describe different stages of chronic renal failure including end stage renal failure. The assessment and management of CKD in patients can be difficult due to many factors such as comorbid conditions, numerous medications, and altered pharmacokinetics. This online module will help pharmacists understand the classification system for kidney dysfunction, and implications for drug dosing. The subject matter expert also discusses medications to avoid in patients with CKD and summarizes common drugs that require dose adjustments.

This presentation has received great uptake at OPA’s Conference 2016.

Learning objectives  

Upon completion of this program, participants will be able to:

  • Discuss the classification system for kidney dysfunction
  • Review changes in the kidney of the elderly
  • Describe ways to prevent the development of kidney disease
  • Summarize common drugs that need dose adjustments
  • Summarize drugs that can cause kidney injury


CEU: 1.0
CCCEP accreditation file number: 

  • 8003-2017-1964-I-P

Expiry date: February 7, 2020

Learning format: 

  • Online, didactic learning module (1 hour)
  • Interactive questions
  • Learner assessment


  • Multiple choice assessment

Program Completion

To receive the letter of completion for this program, participants will be required to complete the following requirements until February 6, 2020:

  1. Complete the program’s online modules (instructions will be emailed to you separately after registration).
  2. Complete the multiple-choice exam and achieve a score of 70 per cent or more within a maximum of two attempts.
  3. Complete the program’s evaluation.
  • Please note: Access to this program is provided until Feb 6, 2020.

Pre-requisites and Target Audience

The Drugs in Chronic Kidney Disease: Implications for Pharmacists online module is designed for pharmacists who wish to gain a better understanding of drug management in patients with CKD.


  • Marisa Battistella, RPh, ACPR (BScPhm, PharmD)
  • Louise Moist, MD (MSc)
  • Lisa Zhu, RPh, ACPR (BScPhm, PharmD)


Last updated: February 7, 2019

Inquiries: Please contact OPA’s professional development team by phone at 416-441-0788, option 3 (toll-free in Ontario at 1-877-341-0788, option 3), or by email at education@opatoday.com.

Cancellation policy: Requests for cancellations must be submitted in writing to education@opatoday.com no later than five days after access to the program has been emailed to you. An administration and processing fee may apply. Cancellations will not be permitted once log-in to access the program material has been initiated. Program registration fees will not be refunded after the cancellation deadline.

Protecting your privacy: Your privacy is important to us. Some information you provide to OPA in program registration forms and exercises may be considered personal information. The Association collects, uses, and shares the information contained in program registration forms and exercises for the sole purposes of processing your registration, issuing certificates/letters of completion, awarding continuing education credits, and delivering OPA services, programs, and publications to you.

Learners’ code of conduct: By registering for an OPA education program, you agree to follow OPA’s Learners’ Code of Conduct. For further details click here

Event Date: Recurring | City: Online | Venue: Online

Pricing and Registration
Member Rate
Chronic Kidney Diease   $15.00 Add to Cart 
Non-Member Rate
Chronic Kidney Diease   $30.00 Add to Cart 
Back to top